Cargando…
Denosumab: mechanism of action and clinical outcomes
AIMS: To describe the mechanisms of action of denosumab, a novel antiresorptive agent, contrasting it with other antiresorptive and anabolic osteoporosis treatments. METHODS: Published papers related to the mechanism of action of approved osteoporosis treatments were sought through MEDLINE searches....
Autores principales: | Hanley, D A, Adachi, J D, Bell, A, Brown, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549483/ https://www.ncbi.nlm.nih.gov/pubmed/22967310 http://dx.doi.org/10.1111/ijcp.12022 |
Ejemplares similares
-
Beneficial effects of an intergenerational exercise intervention on health-related physical and psychosocial outcomes in Swiss preschool children and residential seniors: a clinical trial
por: Minghetti, Alice, et al.
Publicado: (2021) -
Frailty as a predictor of short-term adverse outcomes
por: Coelho, Tiago, et al.
Publicado: (2015) -
Prognostic accuracy of syncope clinical prediction rules in older adults in the emergency department
por: Voigt, Richard D., et al.
Publicado: (2022) -
Improving Parkinson’s Medicine Administration in Hospitals: The Impact of an Out-of-Hours Drug Box
por: Saleem, Anum, et al.
Publicado: (2023) -
Outcomes of hospitalized patients with COVID-19 according to level of frailty
por: Andrés-Esteban, Eva María, et al.
Publicado: (2021)